Status:
COMPLETED
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
Lead Sponsor:
Vanderbilt University
Conditions:
Fatigue
Hodgkin Lymphoma
Eligibility:
All Genders
15-39 years
Brief Summary
Fatigue is one of the most prevalent symptoms endorsed by cancer survivors, particularly those treated for breast cancer or Hodgkin lymphoma. Despite the tremendous implications such work has for effe...
Eligibility Criteria
Inclusion
- Currently 18 years of age or older
- Alive without evidence of recurrent disease
- Must be off therapy (not on active treatment for HL or other malignancies)
- Must not be on any form of chemotherapy (oral or intravenous \[IV\])
- Provide informed consent
- Can read and understand English
- Treated with risk-adapted therapy which may include radiotherapy doses \< 30 Gy
Exclusion
- Evidence of a subsequent malignancy following lymphoma treatment
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01228461
Start Date
February 1 2010
End Date
January 1 2012
Last Update
April 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232